EB-1213

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameEB-1213
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionProtein synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsPsoriasisRenal InsufficiencyNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeo Pharma A/S
Active IndicationsN/A
Inactive IndicationsPsoriasisRenal InsufficiencyNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A